Synthesis, Cytotoxicity, and Pro-Apoptosis Activity of Etodolac Hydrazide Derivatives as Anticancer Agents
作者:Pelin Çıkla、Derya Özsavcı、Özlem Bingöl-Özakpınar、Azize Şener、Özge Çevik、Suna Özbaş-Turan、Jülide Akbuğa、Fikrettin Şahin、Ş. Güniz Küçükgüzel
DOI:10.1002/ardp.201200449
日期:2013.5
Etodolac hydrazide and a novel series of etodolac hydrazide‐hydrazones 3–15 and etodolac 4‐thiazolidinones 16–26 were synthesized in this study. The structures of the new compounds were determined by spectral (FT‐IR, 1H NMR, 13C NMR, HREI‐MS) methods. Some selected compounds were determined at one dose toward the full panel of 60 human cancer cell lines by the National Cancer Institute (NCI, Bethesda
本研究合成了依托度酸酰肼和一系列新型依托度酸酰肼-腙 3-15 和依托度酸 4-噻唑烷酮 16-26。新化合物的结构通过光谱(FT-IR、1H NMR、13C NMR、HREI-MS)方法确定。美国国家癌症研究所 (NCI, Bethesda, USA) 对 60 种人类癌细胞系的全组确定了一些选定的化合物。2-(1,8-二乙基-1,3,4,9-四氢吡喃[3,4-b]吲哚-1-基)乙酸[(4-氯苯基)亚甲基]酰肼9对前列腺癌细胞系 PC-3,在 10-5 M (10 µM) 下具有 58.24% 的生长抑制。使用 MTT 比色法,在体外针对前列腺细胞系 PC-3 和大鼠成纤维细胞系 L-929 评估了化合物 9 在不同剂量下的细胞活力和生长抑制。与依托度酸相比,化合物 9 对 PC-3 细胞表现出抗癌活性,IC50 值为 54 µM (22.842 µg/mL),并且对 L-929 大鼠成